Invasive amebiasis: A microcirculatory disorder?

Medical Hypotheses

Volumn 73, Issue 5, 2009, Pages 687-697

  Campos Rodríguez, Rafael ^a   Jarillo Luna, Rosa Adriana ^a   Larsen, Bruce Allan ^a   Rivera Aguilar, Víctor ^b   Ventura Juárez, Javier ^c  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c Autonomous University of Aguascalientes Centro de Ciencias Basicas   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE DONOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOPLASTIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

AMEBIASIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INVASION; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENTAMOEBA HISTOLYTICA; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIVER AMEBIASIS; MICROANGIOPATHY; NONHUMAN; PARASITE IMMUNITY; PARASITE PREVALENCE; PARASITE SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; THROMBOSIS; VASODILATATION;

EID: 70349841141     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.05.014     Document Type: Article

References (156)

1. Amoebiasis. Wkly Epidemiol Rec 1997;72:97-9.
2. Petri Jr. W.A. Recent advances in amebiasis. Crit Rev Clin Lab Sci 33 (1996) 1-37
3. Petri Jr. W.A., and Singh U. Diagnosis and management of amebiasis. Clin Infect Dis 29 (1999) 1117-1125
4. Aguirre-Garcia J. Histopathological peculiarities of the amebic lesion. Arch Invest Med (Mex) 1970;1(Suppl):147-56.
5. Stanley S.L. Pathophysiology of amoebiasis. Trends Parasitol 17 (2001) 280-285
6. Espinosa-Cantellano M., and Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 13 (2000) 318-331
7. Huston C.D. Parasite and host contributions to the pathogenesis of amebic colitis. Trends Parasitol 20 (2004) 23-26
8. Stanley Jr. S.L. Amoebiasis. Lancet 361 (2003) 1025-1034
9. Ackers J.P., and Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr Opin Microbiol 9 (2006) 367-373
10. Petri Jr. W.A. Pathogenesis of amebiasis. Curr Opin Microbiol 5 (2002) 443-447
11. Perez-Tamayo R., Montfort I., Garcia A.O., Ramos E., and Ostria C.B. Pathogenesis of acute experimental liver amebiasis. Arch Med Res 37 (2006) 203-209
12. Bracha R., Nuchamowitz Y., Leippe M., and Mirelman D. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Mol Microbiol 34 (1999) 463-472
13. Zhang X., Zhang Z., Alexander D., Bracha R., Mirelman D., and Stanley Jr. S.L. Expression of amoebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infect Immun 72 (2004) 678-683
14. Ankri S., Padilla-Vaca F., Stolarsky T., Koole L., Katz U., and Mirelman D. Antisense inhibition of expression of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol Microbiol 33 (1999) 327-337
15. Que X., and Reed S.L. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 13 (2000) 196-206
16. Reed S.L., Keene W.E., and McKerrow J.H. Thiol proteinase expression and pathogenicity of Entamoeba histolytica. J Clin Microbiol 27 (1989) 2772-2777
17. Olivos-Garcia A., Gonzalez-Canto A., Lopez-Vancell R., de Leon G., Mdel C., Tello E., et al. Amebic cysteine proteinase 2 (EhCP2) plays either a minor or no role in tissue damage in acute experimental amebic liver abscess in hamsters. Parasitol Res 90 (2003) 212-220
18. Hellberg A., Nickel R., Lotter H., Tannich E., and Bruchhaus I. Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba dispar increases amoeba-induced monolayer destruction in vitro but does not augment amoebic liver abscess formation in gerbils. Cell Microbiol 3 (2001) 13-20
19. Barrett A.J., and Starkey P.M. The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 133 (1973) 709-724
20. Reed S.L., Keene W.E., McKerrow J.H., and Gigli I. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica. J Immunol 143 (1989) 189-195
21. Tillack M., Biller L., Irmer H., Freitas M., Gomes M.A., Tannich E., et al. The Entamoeba histolytica genome: primary structure and expression of proteolytic enzymes. BMC Genom 8 (2007) 170
22. Gathiram V., and Jackson T.F. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. S Afr Med J 72 (1987) 669-672
23. Moran P., Ramos F., Ramiro M., Curiel O., Gonzalez E., Valadez A., et al. Entamoeba histolytica and/or Entamoeba dispar: infection frequency in HIV+/AIDS patients in Mexico city. Exp Parasitol 110 (2005) 331-334
24. Perez-Tamayo R, Becker I, Montfort I, Perez-Montfort R. Pathobiology of amebiasis. In: Martinez-Palomo A, editor. Amebiasis. Amsterdam: Elsevier; 1986. p. 123-57.
25. Pérez-Tamayo RBI, Montfort I, Pérez-Montfort R. Pathobiology of amebiasis. In: Krestchmer RR, editor. Amebiasis: infection and disease by Entamoeba histolytica. Boca Raton (Florida): CRC Press; 1990. p. 123-57.
26. Petri Jr. W.A., Haque R., and Mann B.J. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol 56 (2002) 39-64
27. Ravdin J.I. Entamoeba histolytica: from adherence to enteropathy. J Infect Dis 159 (1989) 420-429
28. Griffin J.L. Human amebic dysentery. Electron microscopy of Entamoeba histolytica contacting, ingesting, and digesting inflammatory cells. Am J Trop Med Hyg 21 (1972) 895-906
29. Pittman F, Pittman JC, el-Hashimi WK. Human amebiasis. Light and electron microscopy findings in colonic mucosal biopsies from patients with acute amebic colitis. In: Sepulveda B, Diamond LS, editors. Proceedings of the international conference on amebiasis. Mexico, DF; 1976. p. 398-417.
30. Ventura-Juarez J., Barba-Gallardo L.F., Munoz-Fernandez L., Martinez-Medina L., Marquez-Diaz F., Sosa-Diaz S.J., et al. Immunohistochemical characterization of human fulminant amoebic colitis. Parasite Immunol 29 (2007) 201-209
31. Ventura-Juarez J., Campos-Rodriguez R., Rodriguez-Martinez H.A., Rodriguez-Reyes A., Martinez-Palomo A., and Tsutsumi V. Human amebic liver abscess: expression of intercellular adhesion molecules 1 and 2 and of von Willebrand factor in endothelial cells. Parasitol Res 83 (1997) 510-514
32. Perez-Tamayo R, Becker I, Montfort I, Perez-Montfort R. Pathobiology of amebiasis. In: Kretschmer RR, editor, Amebiasis: Infection and disease by Entamoeba histolytica. Boca Raton, Florida: CRC Press; 1990.
33. Quintanar-Quintanar ME, Jarillo-Luna A, Rivera-Aguilar V, Ventura-Juarez J, Tsutsumi V, Shibayama M, et al. Immunosuppressive treatment inhibits the development of amebic liver abscesses in hamsters. Med Sci Monit 2004;10:BR317-324.
34. Tsutsumi V., Mena-Lopez R., Anaya-Velazquez F., and Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 117 (1984) 81-91
35. Green SJ, Turpin JA, Nacy CA. Cytotoxic effector activities of macrophages. In: Rich RR, editor. Clinical immunology principles and practice. Mosby: St Louis, USA; 1996. p. 290-8.
36. Seydel K.B., Li E., Zhang Z., and Stanley Jr. S.L. Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. Gastroenterology 115 (1998) 1446-1453
37. Prathap K., and Gilman R. The histopathology of acute intestinal amebiasis. A rectal biopsy study. Am J Pathol 60 (1970) 229-246
38. Guo X., Houpt E., and Petri Jr. W.A. Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies. Curr Opin Immunol 19 (2007) 376-384
39. Campos-Rodriguezp R., and Jarillo-Luna A. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity. Parasite Immunol 27 (2005) 1-8
40. Huston C.D., and Petri Jr. W.A. Host-pathogen interaction in amebiasis and progress in vaccine development. Eur J Clin Microbiol Infect Dis 17 (1998) 601-614
41. Choi M.H., Sajed D., Poole L., Hirata K., Herdman S., Torian B.E., et al. An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Mol Biochem Parasitol 143 (2005) 80-89
42. MacFarlane R.C., and Singh U. Identification of differentially expressed genes in virulent and nonvirulent Entamoeba species: potential implications for amebic pathogenesis. Infect Immun 74 (2006) 340-351
43. Stanley Jr. S.L., and Reed S.L. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1049-1054
44. Braga L.L., Ninomiya H., McCoy J.J., Eacker S., Wiedmer T., Pham C., et al. Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest 90 (1992) 1131-1137
45. Wang W., and Chadee K. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-A beta mRNA expression by a prostaglandin E2-dependent mechanism. Infect Immun 63 (1995) 1089-1094
46. Wang W., Keller K., and Chadee K. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology 83 (1994) 601-610
47. Gutierrez-Alarcon A., Moguel-Torres M., Mata-Leyva O., Cuellar-Nevarez G., Siqueiros-Cendon T., Erosa G., et al. Entamoeba histolytica: inflammatory process during amoebic liver abscess formation involves cyclooxygenase-2 expression in macrophages and trophozoites. Exp Parasitol 114 (2006) 154-159
48. Dey I., Keller K., Belley A., and Chadee K. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc Natl Acad Sci USA 100 (2003) 13561-13566
49. Utrera-Barillas D., Velazquez J.R., Enciso A., Cruz S.M., Rico G., Curiel-Quesada E., et al. An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines. Parasite Immunol 25 (2003) 475-482
50. Rico G., Leandro E., Rojas S., Gimenez J.A., and Kretschmer R.R. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res 90 (2003) 264-267
51. Hamano S., Asgharpour A., Stroup S.E., Wynn T.A., Leiter E.H., and Houpt E. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J Immunol 177 (2006) 1208-1213
52. Kammanadiminti S.J., Mann B.J., Dutil L., and Chadee K. Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica. Faseb J 18 (2004) 155-157
53. Olivos-Garcia A., Nequiz-Avendano M., Tello E., Martinez R.D., Gonzalez-Canto A., Lopez-Vancell R., et al. Inflammation, complement, ischemia and amoebic survival in acute experimental amoebic liver abscesses in hamsters. Exp Mol Pathol 77 (2004) 66-71
54. Shibayama M., Campos-Rodriguez R., Ramirez C., Pacheco-Yepez J., and Tsutsumi V. Studies on the natural immunity in hamsters using the intraperitoneal model of amebic liver abscess. Arch Med Res 31 (2000) S78-80
55. Ivory C., Kammanadiminti S., and Chadee K. Innate resistance to Entamoeba histolytica in murine models. Trends Parasitol 23 (2007) 46-48
56. Jarillo-Luna R.A., Campos-Rodriguez R., and Tsutsumi V. Entamoeba histolytica: immunohistochemical study of hepatic amoebiasis in mouse. Neutrophils and nitric oxide as possible factors of resistance. Exp Parasitol 101 (2002) 40-56
57. Seydel K.B., Zhang T., and Stanley Jr. S.L. Neutrophils play a critical role in early resistance to amebic liver abscesses in severe combined immunodeficient mice. Infect Immun 65 (1997) 3951-3953
58. Velazquez C., Shibayama-Salas M., Aguirre-Garcia J., Tsutsumi V., and Calderon J. Role of neutrophils in innate resistance to Entamoeba histolytica liver infection in mice. Parasite Immunol 20 (1998) 255-262
59. Petri Jr. W.A., and Ravdin J.I. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun 59 (1991) 97-101
60. Ravdin J.I., Shain D.C., and Kelsall B.L. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica. Vaccine 11 (1993) 241-246
61. Cheng X.J., and Tachibana H. Protection of hamsters from amebic liver abscess formation by immunization with the 150- and 170-kDa surface antigens of Entamoeba histolytica. Parasitol Res 87 (2001) 126-130
62. Trissl D. Immunology of Entamoeba histolytica in human and animal hosts. Rev Infect Dis 4 (1982) 1154-1184
63. Prasad R., Tola M., Bhattacharya S., Sharma M.P., and Bhattacharya A. Recognition of Entamoeba histolytica lipophosphoglycan by a strain-specific monoclonal antibody and human immune sera. Mol Biochem Parasitol 56 (1992) 279-287
64. Petri Jr. W.A., Broman J., Healy G., Quinn T., and Ravdin J.I. Antigenic stability and immunodominance of the Gal/GalNAc adherence lectin of Entamoeba histolytica. Am J Med Sci 297 (1989) 163-165
65. Moran P., Ramos F., Ramiro M., Curiel O., Gonzalez E., Valadez A., et al. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis. Am J Trop Med Hyg 73 (2005) 296-300
66. Ramos F., Moran P., Gonzalez E., Garcia G., Ramiro M., Gomez A., et al. High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community. Am J Trop Med Hyg 73 (2005) 87-91
67. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
68. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1 (1989) 1-13
69. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
70. Abbas A.B.L.A., and Pillai S. Cellular and molecular immunology (2007), Saunders Elsevier, Philadelphia
71. Cario E. Toll-like receptors and gastrointestinal diseases: from bench to bedside?. Curr Opin Gastroenterol 18 (2002) 696-704
72. Zacharowski K., Sucker C., Zacharowski P., and Hartmann M. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 95 (2006) 557-561
73. Beutler B. Sepsis begins at the interface of pathogen and host. Biochem Soc Trans 29 (2001) 853-859
74. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001) 863-869
75. Medzhitov R., and Janeway Jr. C. Innate immunity. N Engl J Med 343 (2000) 338-344
76. Misch E.A., and Hawn T.R. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 114 (2008) 347-360
77. Cook D.N., Pisetsky D.S., and Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5 (2004) 975-979
78. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
79. Hawn T.R., Misch E.A., Dunstan S.J., Thwaites G.E., Lan N.T., Quy H.T., et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37 (2007) 2280-2289
80. Kirschning C.J., and Schumann R.R. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 270 (2002) 121-144
81. Lancaster G.I., Khan Q., Drysdale P., Wallace F., Jeukendrup A.E., Drayson M.T., et al. The physiological regulation of toll-like receptor expression and function in humans. J Physiol 563 (2005) 945-955
82. Hawn T.R., Dunstan S.J., Thwaites G.E., Simmons C.P., Thuong N.T., Lan N.T., et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 194 (2006) 1127-1134
83. Hawn T.R., Verbon A., Lettinga K.D., Zhao L.P., Li S.S., Laws R.J., et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 198 (2003) 1563-1572
84. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
85. Aird W.C. Endothelial cell heterogeneity. Crit Care Med 31 (2003) S221-230
86. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
87. Gerritsen M.E., and Bloor C.M. Endothelial cell gene expression in response to injury. Faseb J 7 (1993) 523-532
88. Gross P.L., and Aird W.C. The endothelium and thrombosis. Semin Thromb Hemost 26 (2000) 463-478
89. Pober J.S., and Cotran R.S. Cytokines and endothelial cell biology. Physiol Rev 70 (1990) 427-451
90. Cotran R.S. American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity. Am J Pathol 129 (1987) 407-413
91. Pober J.S., and Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7 (2007) 803-815
92. Luster A.D., Alon R., and von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6 (2005) 1182-1190
93. Mantovani A., Bussolino F., and Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today 18 (1997) 231-240
94. Silverstein RL. The vascular endothelium. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincot Williams & Wilkins; l999. p. 207-22.
95. Heidemann J., Domschke W., Kucharzik T., and Maaser C. Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?. Infect Immun 74 (2006) 5425-5432
96. Danese S., Dejana E., and Fiocchi C. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178 (2007) 6017-6022
97. Introna M., and Mantovani A. Early activation signals in endothelial cells: stimulation by cytokines. Arterioscler Thromb Vasc Biol 17 (1997) 423-428
98. Maldonado-Bernal C., Kirschning C.J., Rosenstein Y., Rocha L.M., Rios-Sarabia N., Espinosa-Cantellano M., et al. The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4. Parasite Immunol 27 (2005) 127-137
99. Eckmann L., Reed S.L., Smith J.R., and Kagnoff M.F. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J Clin Invest 96 (1995) 1269-1279
100. Sharma M., Vohra H., and Bhasin D. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica: basis of invasive disease. Parasitology 131 (2005) 783-796
101. Yu Y., and Chadee K. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 112 (1997) 1536-1547
102. Yu Y., and Chadee K. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 161 (1998) 3746-3752
103. Hailer N.P., Oppermann E., Leckel K., Cinatl J., Markus B.H., and Blaheta R.A. Prostaglandin E2 induces expression of P-selectin (CD62P) on cultured human umbilical vein endothelial cells and enhances endothelial binding of CD4-T-cells. Transplantation 70 (2000) 236-240
104. Moncada D., Keller K., and Chadee K. Entamoeba histolytica-secreted products degrade colonic mucin oligosaccharides. Infect Immun 73 (2005) 3790-3793
105. Reed S.L., Ember J.A., Herdman D.S., DiScipio R.G., Hugli T.E., and Gigli I. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J Immunol 155 (1995) 266-274
106. Mukherjee R.M., Maitra T.K., Mohimen A., Mehra S., and Jalan K.N. Detection of immune complexes in tissues of persons infected with Entamoeba histolytica. Trans R Soc Trop Med Hyg 88 (1994) 546-547
107. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94 (1994) 1147-1155
108. Vincent J.L., and De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 9 Suppl 4 (2005) S9-12
109. Furie B., and Furie B.C. Thrombus formation in vivo. J Clin Invest 115 (2005) 3355-3362
110. Bateman R.M., Sharpe M.D., and Ellis C.G. Bench-to-bedside review: microvascular dysfunction in sepsis - hemodynamics, oxygen transport, and nitric oxide. Crit Care 7 (2003) 359-373
111. Bick R.L., and Murano G. Physiology of hemostasis. Clin Lab Med 14 (1994) 677-707
112. Vallet B., and Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 29 (2001) S36-41
113. Boettner D.R., and Petri W.A. Entamoeba histolytica activates host cell caspases during contact-dependent cell killing. Curr Top Microbiol Immunol 289 (2005) 175-184
114. Sim S., Yong T.S., Park S.J., Im K.I., Kong Y., Ryu J.S., et al. NADPH oxidase-derived reactive oxygen species-mediated activation of ERK1/2 is required for apoptosis of human neutrophils induced by Entamoeba histolytica. J Immunol 174 (2005) 4279-4288
115. Ince C. The microcirculation is the motor of sepsis. Crit Care 9 Suppl 4 (2005) S13-19
116. Szabó C. Pathopysiological roles of nitric oxide in inflammation. In: Ignarro LJ, editor. Nitric oxide biology and pathobiology. San Diego: Academic Press; 2000. p. 841-72.
117. Roerig S, Wolf R, Grisham MB. Nitric oxide, chronic joint inflammation, and pain. In: Ignarro LJ, editor. Nitric oxide biology and pathobiology. San Diego: Academic Press; 2000. p. 873-94.
118. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88 (1991) 4651-4655
119. Que X., Kim S.H., Sajid M., Eckmann L., Dinarello C.A., McKerrow J.H., et al. A surface amebic cysteine proteinase inactivates interleukin-18. Infect Immun 71 (2003) 1274-1280
120. Fitzner N., Clauberg S., Essmann F., Liebmann J., and Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin Vaccine Immunol 15 (2008) 138-146
121. Zhang H., Rogiers P., Smail N., Cabral A., Preiser J.C., Peny M.O., et al. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock. J Appl Physiol 83 (1997) 1164-1173
122. Chadee K., and Meerovitch E. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am J Pathol 117 (1984) 71-80
123. Wu K.K., and Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 47 (1996) 315-331
124. Dhainaut J.F., Marin N., Mignon A., and Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29 (2001) S42-47
125. Nilsen E.M., Johansen F.E., Jahnsen F.L., Lundin K.E., Scholz T., Brandtzaeg P., et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 42 (1998) 635-642
126. Polunovsky V.A., Wendt C.H., Ingbar D.H., Peterson M.S., and Bitterman P.B. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res 214 (1994) 584-594
127. Pacheco-Yepez J., Campos-Rodriguez R., Shibayama M., Ventura-Juarez J., Serrano-Luna J., and Tsutsumi V. Entamoeba histolytica: production of nitric oxide and in situ activity of NADPH diaphorase in amebic liver abscess of hamsters. Parasitol Res 87 (2001) 49-56
128. Seydel K.B., Smith S.J., and Stanley Jr. S.L. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect Immun 68 (2000) 400-402
129. Ramirez-Emiliano J., Gonzalez-Hernandez A., and Arias-Negrete S. Expression of inducible nitric oxide synthase mRNA and nitric oxide production during the development of liver abscess in hamster inoculated with Entamoeba histolytica. Curr Microbiol 50 (2005) 299-308
130. Li J., and Billiar T.R. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276 (1999) G1069-1073
131. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
132. Unger L.S., Cryer H.M., and Garrison R.N. Differential response of the microvasculature in the liver during bacteremia. Circ Shock 29 (1989) 335-344
133. Brandt HP-TR. Amibiasis. Mexico (DF): Prensa Médica Mexicana; 1970.
134. Aikat B.K., Bhusnurmath S.R., Pal A.K., Chhuttani P.N., and Datta D.V. The pathology and pathogenesis of fatal hepatic amoebiasis - a study based on 79 autopsy cases. Trans R Soc Trop Med Hyg 73 (1979) 188-192
135. Joyce MPRJ. Pathology of human amebiasis. In: Ravdin J, editor. Amebiasis human infection by Entamoeba histolytica. New York; 1988. p. 129-46.
136. Rogers L. Amoewbic liver abscess: its pathology, prevention, and cure. Lancet 1 (1932) 463-469
137. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther 53 (1992) 275-354
138. Rappaport A.M. Hepatic blood flow: morphologic aspects and physiologic regulation. Int Rev Physiol 21 (1980) 1-63
139. Carrera G.M. Pathology of early amebic hepatitis. AMA Arch Pathol 50 (1950) 440-449
140. Soon RK, Jr., Yee HF, Jr. Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis 2008;12:791-803, viii.
141. Bohm F., and Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76 (2007) 8-18
142. Kawada N., Tran-Thi T.A., Klein H., and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213 (1993) 815-823
143. Reynaert H., Thompson M.G., Thomas T., and Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50 (2002) 571-581
144. McCuskey R.S. Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver 20 (2000) 3-7
145. Ventura-Juarez J., Jarillo-Luna R.A., Fuentes-Aguilar E., Pineda-Vazquez A., Munoz-Fernandez L., Madrid-Reyes J.I., et al. Human amoebic hepatic abscess: in situ interactions between trophozoites, macrophages, neutrophils and T cells. Parasite Immunol 25 (2003) 503-511
146. Lin J.Y., and Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from l-arginine. J Immunol 148 (1992) 3999-4005
147. Lin J.Y., Seguin R., Keller K., and Chadee K. Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun 62 (1994) 1534-1541
148. Loftus B., Anderson I., Davies R., Alsmark U.C., Samuelson J., Amedeo P., et al. The genome of the protist parasite Entamoeba histolytica. Nature 433 (2005) 865-868
149. Akbar M.A., Chatterjee N.S., Sen P., Debnath A., Pal A., Bera T., et al. Genes induced by a high-oxygen environment in Entamoeba histolytica. Mol Biochem Parasitol 133 (2004) 187-196
150. Acuna-Soto R., Maguire J.H., and Wirth D.F. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 95 (2000) 1277-1283
151. Klein S.L. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 26 (2004) 247-264
152. Lotter H., Jacobs T., Gaworski I., and Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect Immun 74 (2006) 118-124
153. Burkhardt M., Slotta J.E., Garcia P., Seekamp A., Menger M.D., and Pohlemann T. The effect of estrogen on hepatic microcirculation after ischemia/reperfusion. Int J Colorectal Dis 23 (2008) 113-119
154. Cid M.C., Schnaper H.W., and Kleinman H.K. Estrogens and the vascular endothelium. Ann NY Acad Sci 966 (2002) 143-157
155. Virdis A., Ghiadoni L., Sudano I., Buralli S., Salvetti G., Taddei S., et al. Endothelial function in hypertension: role of gender. J Hypertens Suppl 20 (2002) S11-16
156. Taddei S., Virdis A., Ghiadoni L., Mattei P., Sudano I., Bernini G., et al. Menopause is associated with endothelial dysfunction in women. Hypertension 28 (1996) 576-582